在慢性阻塞性肺病中,干扰素介导的支气管上皮细胞衰老
Hong Guo-Parke1, Oisin Cappa1, Dermot A Linden1
1Queen's University Belfast, Wellcome Wolfson Institute for Experimental Medicine, Belfast, United Kingdom of Great Britain and Northern Ireland.
呼吸道细胞中的细胞衰老驱动慢性阻塞性肺病 (COPD) 病原体,与干扰素通路有关. 抑制这些途径可能会减少COPD患者的衰老和炎症.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 细胞衰老与慢性阻塞性肺病 (COPD) 病原发生有关.
- 支气管上皮质衰老的机制尚不清楚.
研究的目的:
- 为了确定COPD上皮细胞中的细胞衰老是否有助于疾病的发病.
- 为了研究COPD支气管上皮的衰老背后的分子机制.
- 探索干扰素通路抑制剂对细胞衰老的影响.
主要方法:
- 来自COPD和健康受试者的支气管上皮细胞的单细胞RNA测序.
- 对衰老标志物 (p16,p21) 和与衰老相关的分泌表型 (SASP) 的评估.
- 对干扰素-β (IFN-β) 和干扰素- (IFN-γ) 表达的评估.
- 测试JAK-STAT和cGAS-STING途径抑制剂 (巴里西提尼布,C-176) 的疗效.
主要成果:
- 在COPD队列中,细胞衰老基因的表达增加,特别是在基底和俱乐部细胞中.
- 在COPD支气管上皮细胞中增强了p16和p21表达,在患者的肺组织中得到证实.
- 在COPD中IFN-β和IFN-γ水平升高.
- 增加COPD中SASP的产生,通过JAK-STAT或cGAS-STING途径抑制剂减弱.
- 抑制剂抑制了衰老标记物的表达.
结论:
- 慢性肺炎支气管上皮表现出一种老化驱动的表型,由I/II型干扰素介导.
- 抑制JAK-STAT或STING-cGAS干扰素通路可能会缓解COPD中的细胞衰老和慢性炎症.
更多相关视频
10:38Culturing of Human Nasal Epithelial Cells at the Air Liquid Interface
Published on: October 8, 2013
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Management Using Bronchodilators and Corticosteroids
